127 related articles for article (PubMed ID: 7716350)
1. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions.
Foresti V
Respiration; 1995; 62(1):21-6. PubMed ID: 7716350
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
Rossi GA; Felletti R; Balbi B; Sacco O; Cosulich E; Risso A; Melioli G; Ravazzoni C
Am Rev Respir Dis; 1987 Apr; 135(4):885-90. PubMed ID: 2436513
[TBL] [Abstract][Full Text] [Related]
3. Chemical pleurodesis for malignant pleural effusions.
Walker-Renard PB; Vaughan LM; Sahn SA
Ann Intern Med; 1994 Jan; 120(1):56-64. PubMed ID: 8250457
[TBL] [Abstract][Full Text] [Related]
4. Corynebacterium parvum pleurodesis and survival is not significantly influenced by pleural pH and glucose level.
Bilaçeroğlu S; Cağirici U; Perim K; Ozacar R
Monaldi Arch Chest Dis; 1998 Feb; 53(1):14-22. PubMed ID: 9632902
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
[TBL] [Abstract][Full Text] [Related]
6. Pleurodesis with doxycycline or Corynebacterium parvum in malignant pleural effusion.
Salomaa ER; Pulkki K; Helenius H
Acta Oncol; 1995; 34(1):117-21. PubMed ID: 7865226
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum].
Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M
Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567
[TBL] [Abstract][Full Text] [Related]
8. Corynebacterium parvum for malignant pleural effusions.
Foresti V
Thorax; 1995 Jan; 50(1):104. PubMed ID: 7886641
[No Abstract] [Full Text] [Related]
9. [Comparison of the effectiveness and adverse effects of a Corynebacterium parvum vaccine made in Czechoslovakia with Coparvax, a British preparation made by Wellcome, in the treatment of malignant pleural effusions].
Marel M; Melínová L; Bednár M
Cas Lek Cesk; 1989 Aug; 128(34):1071-4. PubMed ID: 2790915
[TBL] [Abstract][Full Text] [Related]
10. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study.
Hillerdal G; Kiviloog J; Nöu E; Steinholtz L
Eur J Respir Dis; 1986 Sep; 69(3):204-6. PubMed ID: 2430825
[TBL] [Abstract][Full Text] [Related]
11. [Current treatment strategy in malignant pleural effusion].
Türler A; Walter M; Schmitz-Rixen T
Wien Klin Wochenschr; 1996; 108(9):255-61. PubMed ID: 8686317
[TBL] [Abstract][Full Text] [Related]
12. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
Millar JW; Hunter AM; Horne NW
Thorax; 1980 Nov; 35(11):856-8. PubMed ID: 7221983
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
Casali A; Gionfra T; Rinaldi M; Tonachella R; Tropea F; Venturo I; De Martino C; Curcio CG
Cancer; 1988 Aug; 62(4):806-11. PubMed ID: 3293763
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases.
Senyiğit A; Bayram H; Babayiğit C; Topçu F; Balci AE; Satici O
Respiration; 2000; 67(6):623-9. PubMed ID: 11124644
[TBL] [Abstract][Full Text] [Related]
16. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions.
Sahin U; Unlü M; Akkaya A; Ornek Z
Respiration; 2001; 68(5):501-5. PubMed ID: 11694813
[TBL] [Abstract][Full Text] [Related]
17. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
18. [Chest drainage combined with intracavitary therapy in neoplastic pleural effusion: comparison of three different protocols].
D'Angelo P; Sacco R; Romessis M; Mucilli F
G Chir; 1993 Jul; 14(6):309-12. PubMed ID: 8398623
[TBL] [Abstract][Full Text] [Related]
19. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax).
Laroche CM; Britton M
Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259
[No Abstract] [Full Text] [Related]
20. Malignant pleural effusions: meaning of pleural-fluid pH determination.
Foresti V; Scolari N; Villa A; Parisio E; De Filippi G; Guareschi G
Oncology; 1990; 47(1):62-4. PubMed ID: 2300387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
